Patent: 6,994,840
✉ Email this page to a colleague
Summary for Patent: 6,994,840
| Title: | Kit for radiolabeling ligands with yttrium-90 |
| Abstract: | Methods and kits for radiolabeling proteins, peptides and ligands with radiolytic isotopes, particularly yttrium-90, are disclosed, whereby sufficient purity, specific activity and binding affinity are achieved such that the radiolabeled protein may be directly administered to a patient without further column purification. Such kits and methods will be particularly useful in bringing radioimmunotherapy to the hospital and outpatient setting for the treatment of cancer. |
| Inventor(s): | Chinn; Paul (Carlsbad, CA) |
| Assignee: | Biogen IDEC Inc. (Cambridge, MA) |
| Application Number: | 09/628,186 |
| Patent Claims: | see list of patent claims |
Details for Patent 6,994,840
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Acrotech Biopharma Llc | ZEVALIN | ibritumomab tiuxetan | Injection | 125019 | 02/19/2002 | ⤷ Try a Trial | 2019-03-01 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 6,994,840
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Austria | 428446 | ⤷ Try a Trial |
| Australia | 4004600 | ⤷ Try a Trial |
| Australia | 780311 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
